Becker, A.P.; Becker, V.; McElroy, J.; Webb, A.; Han, C.; Guo, Y.; Bell, E.H.; Fleming, J.; Popp, I.; Staszewski, O.;
et al. Proteomic Analysis of Spatial Heterogeneity Identifies HMGB2 as Putative Biomarker of Tumor Progression in Adult-Type Diffuse Astrocytomas. Cancers 2024, 16, 1516.
https://doi.org/10.3390/cancers16081516
AMA Style
Becker AP, Becker V, McElroy J, Webb A, Han C, Guo Y, Bell EH, Fleming J, Popp I, Staszewski O,
et al. Proteomic Analysis of Spatial Heterogeneity Identifies HMGB2 as Putative Biomarker of Tumor Progression in Adult-Type Diffuse Astrocytomas. Cancers. 2024; 16(8):1516.
https://doi.org/10.3390/cancers16081516
Chicago/Turabian Style
Becker, Aline P., Valesio Becker, Joseph McElroy, Amy Webb, Chunhua Han, Yingshi Guo, Erica H. Bell, Jessica Fleming, Ilinca Popp, Ori Staszewski,
and et al. 2024. "Proteomic Analysis of Spatial Heterogeneity Identifies HMGB2 as Putative Biomarker of Tumor Progression in Adult-Type Diffuse Astrocytomas" Cancers 16, no. 8: 1516.
https://doi.org/10.3390/cancers16081516
APA Style
Becker, A. P., Becker, V., McElroy, J., Webb, A., Han, C., Guo, Y., Bell, E. H., Fleming, J., Popp, I., Staszewski, O., Prinz, M., Otero, J. J., Haque, S. J., Grosu, A.-L., & Chakravarti, A.
(2024). Proteomic Analysis of Spatial Heterogeneity Identifies HMGB2 as Putative Biomarker of Tumor Progression in Adult-Type Diffuse Astrocytomas. Cancers, 16(8), 1516.
https://doi.org/10.3390/cancers16081516